http://www.biotechdaily.com.au/pages/marc-sinatra-s-bioguides.php

Marc Sinatra's BioGuides

Marc SinatraMarc Sinatra holds a BSc (Hons, Genetics) from the University of Melbourne and an MBA from the Melbourne Business School. He is a keen observer of the biotechnology sector and formerly worked for Bio-21 as a business development manager.

Each month, Marc provides a financial analysis of the Australian biotechnology industry, focusing on a specific company’s intellectual property, stage of development, balance sheet and share price performance. Each company report is a detailed snapshot of the financial state of the enterprise with Marc Sinatra’s recommendation.

Marc also comments on topical issues as and when they occur in his ongoing Bioguide Brief Notes - see below.



 

 

 

 

 

Marc Sinatra's Bioguide Brief Notes:

Topical analyses of companies, mergers 
and issues facing the sector

 


    Feb 16, 2010
Quattuordecim Dies Horribilis - Avexa, Chemgenex, CBio
Feb 9, 2010
Chemgenex, The FDA & Tough Questions		 Feb 5, 2010
Tough Road Ahead For Avexa's ATC		 Dec 14, 2009
Chemgenex's $137m Positive Signal 
Nov 19, 2009
Progen - More Truce Than Resolution		 Oct 7, 2009
Despite Price, Cytopia-YM Deal Good For Both		 Oct 5, 2009
Crunch Time For Avexa's Apricitabine
Sept 25, 2009
Why Is Halcygen Buying Mayne Pharma?		 Sept 9, 2009
Chemgenex ASX's Most Undervalued Biotech		 Sept 3, 2009
Peplin Not A 5-Banger, Anymore
July 29, 2009
Dia-B, Pallane Fully Underwritten, Or Not?		 July 22, 2009
Prima's $25.5 Convertible Note		 July 14, 2009
Delist Or Not Delist?
July 3, 2009
Bioguide Brief: Progen - A New Train Coming? 		June 30, 2009
Polartechnics, Fermiscan Strapped For Cash And The Wedding's Off		 June 22, 2009
Dia-B, Pallane & A Flea In The Ear

May 29, 2009
Bioguide Brief: Dia-B Pallane Merge For '$100m' Viral Test Co

May 21, 2009
Sirtex Free of Dr Bruce Gray, UWA Case; Bioguide Brief: What Gray Case Means For Research

May 18, 2009
Bioguide Brief: Verva, Small Holders And The Unlisted Space
May 13, 2009
Federal Budget		 April 20, 2009
Blessing The Polartechnics-Fermiscan Marriage		 March 30, 2009
The Progen Prize Goes To .... Medigen?
March 11, 2009
Is That A Whiff Of Cash In The Air ?		 March 9, 2009
Progen Kills Avexa Deal; Bioguide Brief: Progen Cops A Kicking		 March 3, 2009
Stemcells Inc Buys Stem Cells For $7m; Bioguide Brief: Stem Cell Sells All But Shell
March 2, 2009
Arana And Under-10s Cricket		 February 25, 2009
Who Contributes To Solagran's Share Price?		 February 16, 2009
Thoratec Buys Heartware For $429m; Bioguide Brief: Deal Hurts Ventracor
February 6, 2009
Progen's Wedding Choices		 January 28, 2009 Cytopia's Uncapped Bid For Progen; Bioguide Brief: Cytopia A Better Partner December 19, 2008
The Metabolic - Polynov Deal 
December 18, 2008
Fair Value IPOs, Cellscreen Direct		 December 2, 2008
Genetic Technologies Frees Breast, Ovarian Cancer Tests; Bioguide: GTG & Corporate Philanthropy		 November 14, 2008
Progen's Beerworth Review On The Money
     

 

 

 

Contact Marc using the form below

email address:
Homepage:
URL:
Comment:

*:
*:
:
*:
Verification:
8 multiply 2 =  Fill in the result